StockSelector.com
  Research, Select, & Monitor Wednesday, July 18, 2018 11:44:22 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Anika Therapeutics Inc.$34.72($.09)(.26%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Anika Therapeutics Inc. vs Biotechnology

Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products and devices that promote the repair, protection and healing of bone, cartilage and soft tissue. These products are based on hyaluronic acid, a naturally-occurring, biocompatible polymer found in the body. Due to its unique properties, hyaluronic acid plays an important role in numerous physiological functions such as the protection and lubrication of soft tissues and joints, the maintenance of the structural integrity of tissues and the transport of molecules to and within cells.




An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $113.4 Mil $92,223.0 Mil
  Market Cap: $511.0 Mil $520,646.9 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
 Growth
  Historic Revenue: 9.7% 44.1%
  Estimated Revenue: (1.1%) 145.4%
  Historic Earnings: (8.8%) (41.7%)
  Estimated Earnings: (24.0%) 8.6%
  Stock Price (1 Year): (24.5%) 57.2%
  Cash per Share: 27.5% 17.4%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: 34.0 48.9
  Price-to-Sales: 4.5 N/A
  Price-to-Book: 1.9 4.7
  Dividend Yield: N/A N/A
  Market Cap: $511.0 Mil $11,077.6 Mil
  Operations
  Net Margin: 28.1% (1,960.5%)
  Gross Margin: 75.9% 75.7%
  Return on Equity: .1 (.3)
  Return on Assets: .1 (.3)
  Balance Sheet
  Current Ratio: 15.8 5.0
  Quick Ratio: 14.1 4.7
  Cash Ratio: 12.0 4.0
  Debt-to-Equity: .1 1.0
  Interest Coverage: N/A 1.8
 Technicals
  Relative-Strength Index: 40.9 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $192.80 $137,877.1 Mil
  Gilead Sciences, Inc.  (GILD) $77.12 $101,904.0 Mil
  Biogen Inc.  (BIIB) $358.51 $75,149.3 Mil
  Celgene Corp.  (CELG) $85.78 $65,958.6 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $365.98 $41,990.1 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.